ERSOT
CPRX

Employees Retirement System of Texas’s Catalyst Pharmaceutical CPRX Stock Holding History

Employees Retirement System of Texas’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-138,000
Closed -$161K – 945
2016
Q1 		$161K Hold
138,000
– – ﹤0.01% 936
2015
Q4 		$338K Hold
138,000
– – ﹤0.01% 901
2015
Q3 		$414K Hold
138,000
– – 0.01% 885
2015
Q2 		$570K Hold
138,000
– – 0.01% 864
2015
Q1 		$598K Buy
+138,000
New +$497K 0.01% 868

Other funds holding CPRX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Employees Retirement System of Texas's CPRX Position: Q2 2016 in Review

Employees Retirement System of Texas sold out of Catalyst Pharmaceutical (CPRX) in Q2 2016, closing a stake of 138,000 shares — an estimated $161K sold.

Employees Retirement System of Texas first reported a position in CPRX in Q1 2015 and held it in 5 quarters. The position peaked at $598K in Q1 2015. 62 funds tracked by Wall St. Rank hold CPRX as of Q2 2016.

  • Employees Retirement System of Texas reported no remaining Catalyst Pharmaceutical position as of Q2 2016 after selling out during the quarter.
  • Employees Retirement System of Texas sold 138,000 Catalyst Pharmaceutical shares in Q2 2016, an estimated $161K.
  • Employees Retirement System of Texas first reported a position in Catalyst Pharmaceutical in Q1 2015 and held it in 5 quarters.
  • Employees Retirement System of Texas's Catalyst Pharmaceutical position peaked at $598K in Q1 2015.
  • 62 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2016.

Based on Employees Retirement System of Texas's 13F filing for Q2 2016, filed 11 Aug 2016.